SPECIAL FEATURE
Patient-Centered Focused Review
COVID-19 and Acute Pulmonary Embolism: A Case Series and Brief Review

https://doi.org/10.1016/j.amjms.2020.12.005Get rights and content

Abstract

The SARS-CoV-2 virus, or COVID-19, is responsible for the current global pandemic and has resulted in the death of over 400,000 in the United States. Rates of venous thromboembolism have been noted to be much higher in those infected with COVID-19. Here we report a case-series of COVID-19 patients with diverse presentations of pulmonary embolism (PE). We also briefly describe the pathophysiology and mechanisms for pulmonary embolism in COVID-19. These cases indicate a need to maintain a high index of suspicion for PE in patients with COVID-19, as well as the need to consider occult COVID-19 infection in patients with PE in the right clinical circumstance.

Keywords

SARS-CoV-2
COVID
Thrombotic
Pulmonary embolism
Hypercoagulable
ARDS

Cited by (0)

View Abstract